Literature DB >> 33907310

Publisher Correction: SARS-CoV-2 spike protein interacts with and activates TLR4.

Yingchi Zhao1, Ming Kuang1, Junhong Li2, Ling Zhu2, Zijing Jia2, Xuefei Guo1, Yaling Hu3, Jun Kong4, Hang Yin4, Xiangxi Wang5, Fuping You6.   

Abstract

Entities:  

Year:  2021        PMID: 33907310      PMCID: PMC8077189          DOI: 10.1038/s41422-021-00501-0

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


× No keyword cloud information.
Correction to: Cell Research 10.1038/s41422-021-00495-9; published online 19 March 2021 We apologize for an error in this paper online published on Mar 19, 2021. There is a mistake on the title where “TRL41” should be “TLR4”. This correction does not affect the description of the results or the conclusion of this work. We apologize for not detecting them before publication and any inconvenience caused. The correct title should be as follows: SARS-CoV-2 spike protein interacts with and activates TLR4
  8 in total

1.  Enhanced neutrophil extracellular trap formation in COVID-19 is inhibited by the protein kinase C inhibitor ruboxistaurin.

Authors:  Rebecca Dowey; Joby Cole; A A Roger Thompson; Rebecca C Hull; Chenghao Huang; Jacob Whatmore; Ahmed Iqbal; Kirsty L Bradley; Joanne McKenzie; Allan Lawrie; Alison M Condliffe; Endre Kiss-Toth; Ian Sabroe; Lynne R Prince
Journal:  ERJ Open Res       Date:  2022-04-04

2.  Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine.

Authors:  Chunfeng Li; Audrey Lee; Lilit Grigoryan; Prabhu S Arunachalam; Madeleine K D Scott; Meera Trisal; Florian Wimmers; Mrinmoy Sanyal; Payton A Weidenbacher; Yupeng Feng; Julia Z Adamska; Erika Valore; Yanli Wang; Rohit Verma; Noah Reis; Diane Dunham; Ruth O'Hara; Helen Park; Wei Luo; Alexander D Gitlin; Peter Kim; Purvesh Khatri; Kari C Nadeau; Bali Pulendran
Journal:  Nat Immunol       Date:  2022-03-14       Impact factor: 31.250

3.  Surface translocation of ACE2 and TMPRSS2 upon TLR4/7/8 activation is required for SARS-CoV-2 infection in circulating monocytes.

Authors:  Yi Yao; Kalpana Subedi; Tingting Liu; Namir Khalasawi; Carla Diana Pretto-Kernahan; Jesse William Wotring; Jie Wang; Congcong Yin; Aimin Jiang; Chunmei Fu; Peter Dimitrion; Jia Li; Jesse Veenstra; Qijun Yi; Kathy McKinnon; John Ernest McKinnon; Jonathan Zachary Sexton; Li Zhou; Qing-Sheng Mi
Journal:  Cell Discov       Date:  2022-09-09       Impact factor: 38.079

Review 4.  Toll-like receptor (TLRs) agonists and antagonists for COVID-19 treatments.

Authors:  Zhi-Mei Liu; Ming-Hui Yang; Kun Yu; Zheng-Xing Lian; Shou-Long Deng
Journal:  Front Pharmacol       Date:  2022-09-07       Impact factor: 5.988

Review 5.  Tissue factor in COVID-19-associated coagulopathy.

Authors:  Saravanan Subramaniam; Hema Kothari; Markus Bosmann
Journal:  Thromb Res       Date:  2022-10-01       Impact factor: 10.407

6.  SARS-CoV-2 Spike Protein 1 Activates Microvascular Endothelial Cells and Complement System Leading to Platelet Aggregation.

Authors:  Luca Perico; Marina Morigi; Miriam Galbusera; Anna Pezzotta; Sara Gastoldi; Barbara Imberti; Annalisa Perna; Piero Ruggenenti; Roberta Donadelli; Ariela Benigni; Giuseppe Remuzzi
Journal:  Front Immunol       Date:  2022-03-07       Impact factor: 7.561

7.  Periodic thermomechanical modulation of toll-like receptor expression and distribution in mesenchymal stromal cells.

Authors:  Xun Xu; Yan Nie; Weiwei Wang; Nan Ma; Andreas Lendlein
Journal:  MRS Commun       Date:  2021-07-08       Impact factor: 2.566

8.  SARS-CoV-2 Infected Pediatric Cerebral Cortical Neurons: Transcriptomic Analysis and Potential Role of Toll-like Receptors in Pathogenesis.

Authors:  Agnese Gugliandolo; Luigi Chiricosta; Valeria Calcaterra; Mara Biasin; Gioia Cappelletti; Stephana Carelli; Gianvincenzo Zuccotti; Maria Antonietta Avanzini; Placido Bramanti; Gloria Pelizzo; Emanuela Mazzon
Journal:  Int J Mol Sci       Date:  2021-07-28       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.